Holiday Inn, Kensington, London, UK (November 23-24, 2020)
Exploring the future of ocular drug development
SMi proudly presents the 4th Annual Ophthalmic Drugs Conference taking place on the 23rd-24th of November 2020, in London.
The global ophthalmic drug market is forecast to surpass $60 billion USD by 2025 with increasing focus from the industry on alternative delivery approaches and improving the effectiveness of the current repertoire of drugs in order to grow away from intravitreal injections and other surgical approaches to ocular therapy. With 50% of the global population predicted to have complications in their sight within the next few decades, ophthalmic medicine is set to become one of the biggest industries in pharmaceuticals.
As Europe’s leading Ophthalmic Drugs conference, we will explore new discoveries in the treatment of ocular disease, innovations in combination technologies, and the utterly unique challenges that are faced in the treatment of one of the most complex organs in the body.
This two-day agenda will offer peer-to-peer networking opportunities with leaders in the ophthalmic sphere, from Heads of Drug Development and Senior Directors of Ophthalmology, all the way to academic forerunners in the research into ocular therapy.
To register or for more information visit: www.ophthalmicdrugs.com/gate2biowl
BENEFITS OF ATTENDING:
WHO SHOULD ATTEND:
ü BOOK BY JUNE 30TH TO SAVE GBP 300
ü BOOK BY SEPTEMBER 30TH TO SAVE GBP100
SOCIAL MEDIA HANDLES
Twitter: @SMiPharm #OphthalmicDrugs
LinkedIn: follow our company page – search ‘SMi Pharma’
Additional Contact Info:
T: +44 (0)20 7827 6088
Gate2Biotech - Biotechnologický portál - Vše o biotechnologiích na jednom místě.
ISSN 1802-2685
Tvorba webových stránek: CREOS CZ
© 2006 - 2024 Jihočeská agentura pro podporu inovačního podnikání o.p.s.
Zajímavé články s biotechnologickým obsahem:
Věda technika výzkum - Přehled zpráv z vědy techniky a výzkumu.
DNA - Lidskou DNA má pohltit polární led
Technologie editace fágů může přinést alternativní léčbu rezistencí
Syntetické nanokomplexy s RNA systémově vypínají geny v plodinách